series-c-plus
Stage
1
Investors
About
BrightGene Bio-Medical Technology Co., Ltd. develops and manufactures pharmaceutical products including formulation products, active pharmaceutical ingredients (APIs), intermediates, and veterinary drugs, supported by innovation and research systems.
Explore BrightGene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.